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Abstract
Background: Microsporidia are obligate intracellular parasites that infect a broad range of vertebrates and invertebrates.
They have been increasingly recognized as human pathogens in AIDS patients, mainly associated with a life-threatening
chronic diarrhea and systemic disease. However, to date the global epidemiology of human microsporidiosis is poorly
understood, and recent data suggest that the incidence of these pathogens is much higher than previously reported and
may represent a neglected etiological agent of more common diseases indeed in immunocompetent individuals. To
contribute to the knowledge of microsporidia molecular epidemiology in HIV-positive patients in Nigeria, the authors tested
stool samples proceeding from patients with and without diarrhea.
Methodology/Principal Findings: Stool samples from 193 HIV-positive patients with and without diarrhea (67 and 126
respectively) from Lagos (Nigeria) were investigated for the presence of microsporidia and Cryptosporidium using Weber’s
Chromotrope-based stain, Kinyoun stain, IFAT and PCR. The Weber stain showed 45 fecal samples (23.3%) with characteristic
microsporidia spores, and a significant association of microsporidia with diarrhea was observed (O.R. =18.2; CI: 95%). A
similar result was obtained using Kinyoun stain, showing 44 (31,8%) positive samples with structures morphologically
compatible with Cryptosporidium sp, 14 (31.8%) of them with infection mixed with microsporidia. The characterization of
microsporidia species by IFAT and PCR allowed identification of Enterocytozoon bieneusi, Encephalitozoon intestinalis and E.
cuniculi in 5, 2 and 1 samples respectively. The partial sequencing of the ITS region of the rRNA genes showed that the three
isolates of E.bieneusi studied are included in Group I, one of which bears the genotype B.
Conclusions/Significance: To our knowledge, this is the first report of microsporidia characterization in fecal samples from
HIV-positive patients from Lagos, Nigeria. These results focus attention on the need to include microsporidial diagnosis in
the management of HIV/AIDS infection in Nigeria, at the very least when other more common pathogens have not been
detected.
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Introduction
Diarrhea and severe weight loss are syndromes described in
HIV patients and known as ‘‘slim disease’’ by sub-Saharan
Africans [1]. This pathology can be produced by several
organisms, and it is commonly associated with Cryptosporidium.
Additionally, microsporidia are considered as emerging pathogens
worldwide and several species are involved in human disease [2].
Among them, Enterocytozoon bieneusi and Encephalitozoon species, E.
intestinalis, E. hellem and E. cuniculi are the most frequently identified
microsporidia in human clinical samples. They have been
described as opportunistic pathogens in human immunodeficiency
virus (HIV)-infected patients and other immunocompromised
patients such as transplant recipients [3,4,5,6,7,8,9,10]. However,
microsporidia have also been detected in HIV-negative individuals
[11,12,13,14,15] and it has been recently suggested that the
incidence of miscrosporidial infections in healthy population is
much higher than previously reported and microsporidia may
represent neglected etiological agents of more common diseases
[16] In HIV-infected patients, especially those with CD4+ T-cell
counts below 100 cells per mm
3, E. bieneusi and E. intestinalis have
been associated with acute and chronic diarrhea
[13,17,18,19,20,21,22].
In the last decade, epidemiological studies of human microspo-
ridiosis, have been strengthened with the improvement of
diagnostic methods and the development of molecular markers
[23]. However, the transmission and sources of infection are not
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35239well understood. The transmission may involve person-to-person
as well as waterborne or food contamination, especially in
developing countries with poor sanitation [24]. In the last few
years several authors have focused on animal microsporidiosis, in
order to elucidate the possible zoonotic origin of human
microsporidiosis. In fact, human microsporidia species have been
isolated from a large number of domestic and wild animals
[25,26,27,28]. This zoonotic transmission is supported by
phylogenetic studies which demonstrate that several genotypes
can infect both humans and animals [29,30,31,32].
The introduction of highly active antiretroviral therapy
(HAART) with protease inhibitors to treat HIV/AIDS patients
have substantially decreased the incidence of microsporidiosis in
Europe [33]. However the situation differs in developing countries,
where the rapid expansion of AIDS together with limited access to
HAART has contributed to an increased incidence of this disease.
In the studies carried out in Africa to evaluate the prevalence of
microsporidiosis in HIV–infected patients due to E. bieneusi and
Encephalitozoon species, a variable incidence ranging from 7 to 51%
was obtained, depending on the population studied and the
diagnostic methods used [11,34,35,36,37,38,39,40,41]. Unfortu-
nately, epidemiological studies of microsporidiosis based in
genotyping methods are scarce in these countries
[42,43,44,45,46], so there is still insufficient information on the
magnitude of the microsporidial infection in African countries.
The most likely explanations are the lack of an easy to make
diagnostic method specific for the detection of the parasite and the
lack of experienced and skilled microscopists able to detect the
organism in biological samples.
With the aim of contributing to the knowledge of the molecular
epidemiology of microsporidia in Nigeria, we performed a study in
HIV-infected patients with and without diarrhea. Additionally,
and simultaneously, the presence of Cryptosporidium in these patients
was also determined.
Materials and Methods
Ethics Statements
The protocol and studies were approved by the Institutional
Review Board of the College of Medicine of the University of
Lagos, Nigeria (CMUL) and the Nigerian Institute of Medical
Research (NIMR), Yaba, Lagos, Nigeria. All participants gave
informed consent before their samples were collected and
processed.
Study Population
A total of 193 patients were enrolled in the study, all of them
were HIV–infected patients attending to referral clinics in Lagos,
Nigeria, 67 (34.7%) with and 126 (65.3%) without diarrhea.
Chronic diarrhea was either continuous, defined by the Center for
Disease Control and Prevention as two or more loose stools per
day for more than 28 days; or acute, defined as episodes of two or
more loose stools per day alternating with episodes of formed
stools for less than 28 days. Complete medical histories were
obtained from the hospital records (Demographic and Clinical) for
patients included in the study.
Stool Sample Collection, Storage and Staining Methods
Fresh stool samples were collected in clean universal bottles
labeled with each patient’s details. Samples were stored at -80uC
until use. Thin smears were made from all fecal samples to be
stained with Webers Cromothrope stain and Kinyoun stain to
detect the presence of microsporidia and tentatively Cryptosporidium
sp [47,48].
Indirect Immunofluorescence Antibody Test (IFAT)
This was performed on all samples which tested positive by
Webers Cromothrope stain. IFAT was performed by coating the
slides with 5 ml of each unconcentrated stool sample. Specific
polyclonal antibodies from rabbit for E. hellem (1/500), E. intestinalis
and E. cuniculi (1/400) [49,50,51] and a monoclonal antibody for
E. bieneusi [52] were used. Subsequently, the fluorescein isothio-
cyanate-conjugated anti-rabbit (Sigma Cat. F-9887) and anti-
mouse (Sigma Cat. F-1010) were appropriately diluted and the
slides were examined with a fluorescence microscope.
Molecular Analyses
DNA isolation. DNA from fecal samples found to be positive
for microsporidia by the staining method was extracted by bead
disruption of spores using the Fast-DNA-Spin kit, according to the
manufacturers instructions (Bio 101, Carlsbad, Calif.). PCR
inhibitors were removed using the QIAquick PCR kit
(QIAGEN, Chatsworth, CA).
Species characterization by PCR. Microsporidial small
subunit rRNA (SSU-rRNA) coding regions were amplified using
the following species-specific primers EBIEF1/EBIER1 for E.
bieneusi [53], SINTF/SINTR for E. intestinalis [54], ECUNF/
ECUNR for E. cuniculi and EHELF/EHELR for E. hellem [55].
PCR amplification was performed with the GeneAmp kit (Perkin-
Helmer Cetus, Norwalk, CT) according to the manufacturer
instructions. The conditions for the reaction and the testing of
purified samples for the presence of PCR inhibitors by spiking the
samples with the corresponding cloned SSU-rRNA coding region
was as described [56].
Genotyping by DNA sequencing analysis. E. bieneusi
genotypes from 3 fecal samples were analyzed by nucleotide
sequencing of the Internal Transcribed Spacer (ITS) of the rRNA
genes. The PCR products were purified using Concerted Rapid
PCR kit (GIBCO-BRL) and sequenced in both directions using an
ABI Big Dye Terminator kit (v1.1) and an ABI 3100 automated
sequencer (Applied Biosysytems). The sequences were edited with
BIOEDIT 7.0 program [57] and aligned following the Clustal W
algorithm [58].
Phylogenetic analyses. These were performed by
comparison with 179 sequences available in the GenBank
obtained from different hosts and reviewed by Henriques-Gil et
al 2010 [59]. The haplotypes were generated with the program
DNASP 4.10 [60], without considering the occasional gaps.
Haplotype Median Joining networks [61] were performed with
NETWORK 4.5.1.0 program (Fluxus Technology Ltd.). The
network was simplified reducing star-like clusters to the ancestral
haplotypes with a single run of star contraction [62].
Statistical Analyses
The chi-square test (SPSS 15.0) was used to demonstrate the
association between diarrhea and microsporidia or Cryptosporidium
identification in fecal samples, and the correspondent odds ratio
was calculated.
Results
Staining Methods
Forty-five stool samples (23.3%) showed a variable number of
spores that stained pinkish red with the use of Weber’s
Chromotrope, showing the typical characteristics of microspo-
ridia (Table 1). These spores measured 1 to 2 mm and were
ovoid in shape with a clear vacuole-like polar zone. From the 45
stool samples microsporidia positive by stain, 37 (52.2%) were
obtained from patients with diarrhea and 8 (6.3%) from non-
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spores in fecal samples from patients with diarrhea was
compared with that from patients with no diarrhea, revealing a
clear association between microsporidia and diarrhea with O.R.
= 18.2 (x
2= 58.44; p, 10
–6).
Structures morfologically compatible with Cryptosporidium sp
were detected in 44 of the HIV patients (22.7%) using Kinyoun
stain. Thirty-two of positive patients presented diarrhea and 12
were found in non-diarrheic samples, supporting the well-known
influence of Cryptosporidium sp on diarrhea (x
2=36,34; p, 10
–6 ;
OR=8,7) (Table 1). Mixed infection was recorded between
microsporidia and Cryptosporidium sp in 14 patients (31.8% of
positives) (Table 1). In patients with diarrhea, the two types of
microorganisms could be considered antagonistic as mixed-
infections were lower than expected (x
2=10.77; p, 0.01)
(Table 1).
IFAT
The study by IFAT of microsporidia positive samples showed 8
positive samples. Five samples exhibited bright fluorescence when
E. bieneusi monoclonal antibody was used; two reacted with E.
intestinalis polyclonal antibody and one with E. cuniculi polyclonal
antibody. Spores which reacted with the anti-E. cuniculi and anti-E.
intestinalis polyclonal antibodies were observed in non-diarrheic
samples, and E. bieneusi spores were identified in 1 non-diarrheic
and 4 diarrheic samples by the monoclonal antibody used
(Table 2).
PCR
A total of 7 cases, five for E. bieneusi and 2 for E. intestinalis were
confirmed by amplification of DNA isolated from positive samples
in the staining technique with specific primers for the most
common microsporidia infecting humans (Table 2).
DNA Sequencing Analysis
Three PCR positive samples for E. bieneusi yielded enough PCR
products for partial sequencing of the ITS region of the rDNA
genes. The Nigerian genotypes reported here are included in
Group I. For comparison with 172 sequences from the GenBank,
the gaps were excluded, and 139 sites were available for analysis.
Fifty sites were polymorphic and generated 60 different haplo-
types. One of the sequences obtained from the Nigerian isolates
showed the same haplotype as genotype B [30]. Since we were
unable to analyze the entire ITS, the sequences of the other two
isolates coincided with several similar genotypes: P, type IV,
UG2145, Peru3, PtEb IV or PtEbV [63]. The diversity in the ITS
of E. bieneusi is very high but, within Group I, the differences
between any pair of sequences involve only a small number of
mutational events.
In order to locate the Nigerian samples within the wide
variability of E. bieneusi, Median Joining networks were constructed
with the program NETWORK [61]. The network was simplified,
reducing star-like clusters to the ancestral haplotypes with a single
run of star contraction [62]. The network with the resulting 40
taxa is shown in Figure 1. Nigerian haplotypes, together with the
other African isolates previously analyzed, occupy a central
position in the network.
Discussion
Diarrhea caused by opportunistic agents such as microsporidia,
Cryptosporidium species or Isospora belli contributes to morbidity and
mortality in AIDS patients. In developing countries, these
infections taken together may likely account for a great number
of cases of diarrhea in HIV/AIDS patients [64]. To date there is
only two reports included in PubMed of microsporidia infection in
patients from Nigeria. In the study carried out in a rural village
(Magama Gumau) and in a township in north central Nigeria a
prevalence of 39.6% and 47.3% in rural and urban dwellers was
reported [41]. However, the stain method used to detect
microsporidia was not Webers reference method or Gram-
chromotrope stain and no characterization of the microsporidia
species was made. More recently, a study was carried out in
children attending an outpatient department of a hospital in Oyo
state, southwestern Nigeria [46]. Using PCR, 9.3% of the children
were identified as positive for E.bieneusi. Therefore, to contribute to
a more complete knowledge of microsporidia epidemiology in
Nigeria, this study has evaluated and characterized the presence of
microsporidia in 193 fecal samples from HIV-positive patients
with and without diarrhea (67 and 126 samples respectively);
showing 45 positive samples (23.3%) when Webers stain was used.
Most of the positive samples were identified in diarrheic stools
(52.2%) and only 8 in non-diarrheic stools (6.3%), showing a
significant association between microsporidia and diarrhea in the
population studied (OR = 18.2) such as had previously been
reported in other countries [13,18,19,22,65]. Our results are in
accordance with previous studies on the prevalence of microspo-
ridia in HIV-positive patients, which ranges from 5 to 50%
depending on the geographical location and the diagnostic
technique employed [66]. This suggests that microsporidia are
becoming highly prevalent intestinal parasites in developing
countries such as Nigeria and thus the need to consider them as
neglected etiological agents [16]. In reference to the African
continent, our results are also in accordance with previous studies
in HIV-positive patients with chronic diarrhea [67,68].
Table 1. Fecal samples for Microsporidia and Cryptosporidium
sp by staining methods.
Diarrhea Microsporidia Cryptosporidium sp
Total (%)
Positive
(%)
Negative
(%)
Positive
(%)
Negative
(%)
Yes 67 (34.7) 37 (52.2) 11 (29.7) 26 (70.3)
30 (47.8) 21 (70) 9 (30)
No 126 (65.3) 8 (6.3) 3 (37.5) 5 (62.5)
118 (93.7) 9 (7.6) 109 (92.4)
Total (%) 193 (100) 45 (23.3) 148 (76.7) 44 (22.7) 149 (77.3)
doi:10.1371/journal.pone.0035239.t001
Table 2. Microsporidian species identified by IFAT and PCR in
fecal samples.
Diarrhea IFAT PCR
Species n Species n
Yes E. bieneusi 4 E. bieneusi 4
No E. bieneusi 1 E. bieneusi 1
E. intestinalis 2 E. intestinalis 2
E. cuniculi 1
n= number of samples.
doi:10.1371/journal.pone.0035239.t002
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study, two additional methods were used: IFAT and PCR (the gold
standard). The use of IFAT allowed the identification of
microsporidia species in only 8 fecal samples (Table 2).We
detected a low positive result by IFAT compared with Webers
staining. However, the scarce parasitic load and the low specificity
of Weber’s staining could be related with the differences observed.
However, we can not discard the possibility that other microspo-
ridia species were present in our samples.
In our study most of the positive samples by IFAT were E.
bieneusi (4) followed by E. intestinalis (2).These results are supported
by the fact that E. bieneusi and E. intestinalis are the most prevalent
intestinal microsporida previously described in other countries
including Africa [2,40,42,46,67,72,73,74,75], and E. cuniculi has
only occasionally been found in the intestine of HIV-positive
patients [12].
The PCR method identified 7 positive samples belonging to the
species E. bieneusi and E. intestinalis (Table 2). The PCR technique is
believed to be the most sensitive method for species identification,
but it is expensive and not affordable in many clinical diagnostic
laboratories. In the case of stool samples, the main problem is the
appearance of false-negative results due to a low parasite-DNA
concentration, and the presence of PCR inhibitors [13,69,70].
Following from this, we should point out that we found a high
presence of PCR inhibitors that had not been eliminated by the
usual common methods [53,55]. This fact is supported by the
number of control samples spiked with the cloned microsporidia
DNA which were impossible to amplify. Their proportion was
higher than those usually found in previous studies with fecal
samples from other countries [49,71]. We can only speculate that
the characteristics of the diets or treatments followed by these
patients may contain PCR inhibitors. In addition to the above
difficulties, it is also necessary to consider that human samples
positive by the staining methods may not necessarily amplify with
the specific primers used, due to other causes such as the possible
presence of microsporidia other than the species studied, the
overload of extruded spores in samples containing a low parasitic
load, etc. The positive PCR results (3.6%) are much lower than
those previously obtained, also by PCR, in Zimbabwean HIV-
positive patients (51%) [67]. However, in a study carried out in
Mali, a country nearer Nigeria, E. bieneusi was found in 6.8% of
HIV-positive patients and in 9% of HIV-negative individuals [72],
and these data also correlates with the 9.3% of children recently
identified in Nigeria as positive for E. bieneusi [46].
Few studies on microsporidia exist in Africa, but previous
reports identified E. bieneusi as the most prevalent microsporidia
infecting humans [40,42,46,67,72,73,74,75]. In the present report,
E. bieneusi is described for the first time as the most prevalent
microsporidia in HIV-positive patients with diarrhea in Nigeria.
Additionally, E. intestinalis was also detected for the first time in this
Figure 1. Median-joining network for the different haplotypes. Circles are proportional to the frequency of each haplotype. The colour of
each sector refers to the host species: Nigerian samples (squared sectors), other African haplotypes (black), Europe and Asia (grey lines), North and
South America (white). The lengths of the segments are proportional to the number of mutations involved between two haplotypes.
doi:10.1371/journal.pone.0035239.g001
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E. bieneusi/E. intestinalis but a without specific differentiation been
performed. It is interesting to note the detection of E. cuniculi by
IFAT in a fecal sample, although there are no previous references
of this microsporidia in humans from the African continent. It is
also noteworthy that in a study carried out in Nigeria in domestic
rabbits, an E. cuniculi seropositivity of 16.5% was described,
suggesting the zoonotic origin of this infection [76].
A high intraspecific variability in E. bieneusi has been described
by several authors based on ITS of the rRNA gene. Most
sequences found up to now for the ITS of E. bieneusi belong to
Group I, including those found in our samples, and only a
minority to divergent Groups II, III and IV [59]. Recently, Breton
et al., [43] reported the prevalence in Cameroon and Gabon of
several genotypes (A, B, D, K) included in Group I of the most
common E. bieneusi haplotypes, and a divergent genotype CAF4
(Group II) whose significance is not yet clear [59]. It has been
suggested that some genotypes of E. bieneusi could possibly be host
adapted genotypes and may be of importance to public health with
reference to specific animal groups [77]. However, a recent
phylogenetic analysis showed that humans may become infected
by E. bieneusi from different sources, including human-to-human,
but there is also a certain degree of host-specificity [59]. The
sequences of the three Nigerian samples were similar to previously
described genotypes found in E. bieneusi isolates from Africa,
Europe, Asia and North and South America, and also from a
number of different host species, including humans, cattle, pets
and wild animals [30,59,78]. According to their position in the
network (Figure 1) they presumably represent the most ancient
haplotypes of E. bieneusi. It is interesting to note that such central
locations in the network apply to all the haplotypes found so far in
Africa, including those recently reported by Ayinmode et al. [46].
This result supports the idea that genotypes of E.bieneusi found in
HIV-positive patients are closely related to those from several
animals, thereby supporting the possibility of zoonotic transmis-
sion of the strains.
Finally, the prevalence of Cryptosporidium was established in
22.7% of the 193 fecal samples studied, with 47.7% and 9.5% in
diarrheic and non-diarrheic samples respectively. These data are
similar to those found for microsporidia using Trichrome stain
(23.3% total, and 52.2% and 6.3% in diarrheic and non-diarrheic
samples respectively), and are in accordance with previous reports
indicating that Cryptosporidium infection is not the primary cause of
diarrhea in HIV-positive patients in Africa [40,67,72]. Moreover,
microsporidia and Cryptosporidium were found coinfecting 30% of
Cryptosporidium positive patients in this study, although this was not
surprising as it is consistent with previous observations of both
parasites in HIV/AIDS patients [65,67,79,80,81].
In conclusion, our results provide new data on microsporidia
epidemiology on the African continent, where the control of HIV/
AIDS is already due to limited access to HAART. Because of this,
the presence of chronic intestinal microsporidiosis and cryptospo-
ridiosis should be suspected in HIV/AIDS infected patients with
persistent diarrhea, malabsorption and progressive weight loss.
More importantly, there is further need to investigate other clinical
and environmental samples in order to identify the major sources
of these pathogens in human, in the environment.
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